Jean-Paul Clozel
Jean-Paul Clozel is a prominent Swiss biopharmaceutical entrepreneur best known as the co-founder of Actelion Pharmaceuticals, which was sold to Johnson & Johnson for $30 billion in 2017. He and his wife, Martine Clozel, established Actelion in 1997 after leaving Roche, driven by their commitment to develop treatments for pulmonary hypertension. Despite health challenges in recent years, he continues to lead Idorsia, their second venture, where he has invested significantly, striving to overcome current financial difficulties.
Born on Apr 01, 1953 (72 years old)
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Switzerland | 1 | 5.00 | 0.09% | +0% | 8,654,622 | 7,679 | $700,000 | 621$ |
| Totals | 1 | 8,654,622 | 7,679 | $700,000 | 621$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Switzerland:
Jean-Paul Clozel is a co-founder of Actelion and currently involved with Idorsia, facing challenges in the biotech industry.
5